News
CORT ▼ -3.6% - Corcept Therapeutics Incorporated
CORT ▼ -3.6% - Corcept Therapeutics Incorporated
$CORT reported Q3 2026 EPS of $1.01, beating the $0.81 estimate by 24.7%. Revenue of $340.5M beat the $334.9M estimate by 1.7%.
03-NOV-2026 04:14 PM ET
Share this post
More filings for $CORT
CORT ▼ -6.3% - Corcept Therapeutics IncorporatedNov 3, 2026CORT - Corcept Therapeutics Incorporated - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026CORT ▲ +0.3% - Corcept Therapeutics IncorporatedOct 27, 2026CORT ▼ -1.0% - Corcept Therapeutics IncorporatedOct 26, 2026CORT ▼ -1.0% - Corcept Therapeutics IncorporatedOct 26, 2026CORT ▼ -13.2% - Corcept Therapeutics IncorporatedOct 23, 2026
View full $CORT filing history →💬 Comments
Loading comments…
Leave a comment